Molmed

Developer of gene and cell therapies for the treatment of cancer and rare diseases

placeMilano, Umbria, Italy calendar_todayFounded 1996 groups223 employees language molmed.com

Innovation

22 patent families (14 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,930 times.

YearFilings
20145
20158
20165
20176
20183
20196
20202
20213
20221
20231
20241
20251

Investor mix

2 investors on record.

Investor typeCountShare
Private equity150%
Other / undisclosed150%
Coming soon